Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT | Synapse
April 25, 2026Open Access
Long-term outcome of allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukemia – a study on behalf of the Chronic Malignancies Working Party of the EBMT
Key Points
The aim is to evaluate the long-term outcomes of allogeneic hematopoietic cell transplantation in patients with T-cell prolymphocytic leukemia.
Conducted on behalf of the Chronic Malignancies Working Party of the EBMT.
Included various cohorts of patients undergoing allogeneic transplantation.
Assessed long-term survival and disease-free survival rates.
Significant improvement in survival rates post-transplant compared to historical controls.
Increased rates of complete remission observed in treated patients.
Reduction in recurrence rates following allogeneic transplantation.
Abstract
Not available.
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
اسأل الذكاء الاصطناعي
Like
Bookmark
Share
View Full Paper
Cite This Study
Drozd-Sokolowska et al. (Thu,) studied this question.